Zai Lab Limited
ZLAB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.11 | 0.03 | 0.02 | -0.01 |
| FCF Yield | -10.67% | -78.25% | -133.49% | -97.22% |
| EV / EBITDA | -9.78 | 1.40 | 1.60 | 0.53 |
| Quality | ||||
| ROIC | -27.49% | -43.62% | -37.19% | -49.27% |
| Gross Margin | 62.94% | 64.08% | 65.58% | 63.80% |
| Cash Conversion Ratio | 0.84 | 0.59 | 0.83 | 0.78 |
| Growth | ||||
| Revenue 3-Year CAGR | 22.88% | 22.72% | 63.77% | 123.16% |
| Free Cash Flow Growth | -33.74% | 47.36% | 30.90% | -150.60% |
| Safety | ||||
| Net Debt / EBITDA | 1.26 | 2.12 | 2.27 | 1.38 |
| Interest Coverage | -125.16 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 3.71 | 2.14 | 2.34 | 2.76 |
| Cash Conversion Cycle | -68.86 | -170.26 | -86.96 | -610.48 |